The cells were incubated for 10 min at room temperature with HBSS (basal control), the test compound or the reference agonist and then lysed
There is no confirmed evidence that retatrutide causes thyroid cancer in humans
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles $119.00 per year only $9.92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
However, individual European countries then negotiate pricing and reimbursement, which adds another 6 to 18 months before the drug is actually available at pharmacies in each country
For women taking supplements daily, this layer of verification is particularly meaningful: it addresses not just whether the labeled ingredients are present at the right dose, but whether anything harmful is present that should not be there at all